Arrowhead Pharmaceuticals Inc ARWR:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
69.30quote price arrow up+0.30 (+0.43%)
Volume
11,957
Close
69.00quote price arrow down-0.56 (-0.81%)
Volume
1,597,960
52 week range
19.51 - 92.60

...

Loading . . .

KEY STATS

  • Open70.00
  • Day High70.50
  • Day Low62.99
  • Prev Close69.56
  • 52 Week High92.60
  • 52 Week High Date02/10/21
  • 52 Week Low19.51
  • 52 Week Low Date03/18/20
  • Market Cap7.162B
  • Shares Out103.79M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • 1 Year % Change93.87

RATIOS/PROFITABILITY

  • EPS (TTM)-1.00
  • P/E (TTM)-68.74
  • Fwd P/E (NTM)-305.31
  • EBITDA (MRQ)-105.828M
  • ROE (MRQ)-21.50%
  • Revenue (MRQ)79.84M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-128.52%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Arrowhead Pharmaceuticals Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference mechanism to induce knockdown of target genes. The Company is focused on developing drugs for diseases with a genetic basis, characterized by the overproduction of one or more...
Douglass Given M.D., Ph.D.
Chairman
Christopher Anzalone Ph.D.
Chief Executive Officer
Kenneth Myszkowski
Chief Financial Officer
Address
177 E Colorado Blvd, Suite 700
Pasadena, CA
91105
United States